Business
First Patient Dosed in ATL1102 Phase IIb DMD Trial
First Patient Dosed in ATL1102 Phase IIb DMD Trial
About this update from Percheron Therapeutics Limited
[{"type":"text","content":"Percheron Therapeutics Limited has released a press release. View Attachment","length":251,"tagName":"div"}]